Bruker Corporation (BRKR) vs Caris Life Sciences, Inc. (CAI)
A side-by-side comparison of Bruker Corporation and Caris Life Sciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BRKR
Bruker Corporation
$60.81HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
CAI
Caris Life Sciences, Inc.
$27.78HealthcareDelayed quote: Oct 6, 2026, 2:25 PM EDT
Total return — BRKR vs CAI
growth of $100 · dividends reinvested · last 1yBRKR +67.9% (+67.9%/yr)CAI +8.5% (+8.5%/yr)BRKR compounded faster over this window
BRKR CAI
BRKR vs CAI: by the numbers
- •BRKR is the larger company ($9.26B vs $7.85B market cap).
- •CAI is profitable (10.62% net margin) while BRKR runs a net loss (-2.03%).
- •CAI grew revenue faster over the past five years (26.15% vs 9.10% CAGR).
- •BRKR pays a dividend (0.23% yield), while CAI has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | BRKR | CAI |
|---|---|---|
| P/E ratio | N/A | 77.62 |
| Forward P/E | 28.66 | 239.42 |
| P/S ratio | 2.65 | 7.94 |
| P/B ratio | 3.86 | 13.27 |
| EV / EBITDA | 30.81 | 43.75 |
| FCF yield | 1.01% | 1.87% |
Profitability
| Metric | BRKR | CAI |
|---|---|---|
| Gross margin | 46.69% | 69.66% |
| Operating margin | 3.61% | 5.56% |
| Net margin | -2.03% | 10.62% |
| ROE | -2.97% | 17.77% |
| ROIC | 2.56% | 14.76% |
Dividends
| Metric | BRKR | CAI |
|---|---|---|
| Dividend yield | 0.23% | N/A |
Growth (annualized)
| Metric | BRKR | CAI |
|---|---|---|
| Revenue CAGR (5Y) | 9.10% | 26.15% |
| FCF CAGR (5Y) | -21.33% | N/A |
| Total return CAGR (5Y) | -3.42% | N/A |
Frequently asked
- Which has grown faster, BRKR or CAI?
- Over the past five years, CAI grew revenue faster — BRKR at a 9.10% CAGR versus CAI at 26.15%.
- Does BRKR or CAI pay a bigger dividend?
- BRKR pays a dividend (0.23% yield), while CAI has no payments in the available dividend history.
- Is BRKR or CAI more profitable?
- CAI runs the higher net margin — BRKR at -2.03% versus CAI at 10.62%.
Go deeper
Dig into the metrics
Caris Life Sciences P/E ratioBruker dividend yieldBruker ROECaris Life Sciences ROEBruker operating marginCaris Life Sciences operating marginBruker revenue growthCaris Life Sciences revenue growthBruker free cash flowCaris Life Sciences free cash flow
Bruker & Caris Life Sciences appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.